RELMADA THERAPEUTICS, INC. — Director's Dealing 2015

Jan 16, 2015

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: RELMADA THERAPEUTICS, INC. (RLMD)
CIK: 0001553643
Period of Report: 2015-01-06

Reporting Person: SETH SANDESH (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options/Warrants	$1.50	2024-02-26	Common Stock (48662)		Direct

Footnotes

F1: The options were granted on February 26, 2014 (the "Grant Date"). The stock options vest on the Grant Date based on the following vesting schedule: Twenty-five percent (25%) of the stock options of the initial grant shall vest on the first anniversary of the Grant Date and the remaining seventy-five percent (75%) shall vest in equal quarterly increments of 6.25% of the option grant over the following three (3) year period.

F2: Does not include warrants to be granted to Mr. Seth and/or his affiliates held by the placement agent in connection with the following transactions consummated by the company: (i) an offering that closed on September 30, 2013 (an aggregate of 1,250,000 warrant shares exercisable at $0.80 per share to be allocated to designees of the placement agent), (ii) the going public offering that commenced in May 2014 (an aggregate of 4,290,950 warrant shares exercisable at $1.50 per share to be allocated to designees of the placement agent), (iii) the transaction with Medeor, Inc. that closed on December 31, 2013 (an aggregate of 200,000 warrant shares exercisable at $1.10 per share to be allocated to designees of the placement agent), and (iv) the notes financing that was conducted by the Company in 2012 and 2013 (an aggregate of 140,625 warrant shares exercisable at $0.80 per share to be allocated to designees of the placement agent). In addition, does not include warrants to be granted to Mr. Seth and/or his affiliates by an advisory firm of the Company (an aggregate of 8,655,783 warrant shares exercisable at $0.001 per share to be allocated to designees of the advisory firm).